Aptevo Therapeutics Inc. Proceeds from Contributions from Parent
Aptevo Therapeutics Inc. (APVO) reported Proceeds from Contributions from Parent of $71.22 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributionsFromParent · last filed 2018-03-13
- Aptevo Therapeutics Inc. proceeds from contributions from parent for the quarter ending 2016-12-31 was $26.22M, a 173.97% increase year-over-year.
- Aptevo Therapeutics Inc. proceeds from contributions from parent for the quarter ending 2016-09-30 was $11.43M, a 21.75% increase year-over-year.
- Aptevo Therapeutics Inc. proceeds from contributions from parent for the quarter ending 2016-06-30 was $19.77M.
- Aptevo Therapeutics Inc. proceeds from contributions from parent for the quarter ending 2016-03-31 was $13.80M.
- Aptevo Therapeutics Inc. proceeds from contributions from parent for fiscal 2016 was $71.22M, a 36.38% increase from fiscal 2015.
- Aptevo Therapeutics Inc. proceeds from contributions from parent for fiscal 2015 was $52.22M.
| Period end | Proceeds from Contributions from Parent 3 month | Proceeds from Contributions from Parent 6 month | Proceeds from Contributions from Parent 9 month | Proceeds from Contributions from Parent 9 month as first filed | Proceeds from Contributions from Parent 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $26.22M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $37.65M derived: sum of 2 quarters · filed 2018-03-13 | $57.42M derived: sum of 3 quarters · filed 2018-03-13 | $71.22M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $11.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $31.20M derived: sum of 2 quarters · filed 2017-11-13 | $45.00M 10-Q · filed 2017-11-13 | $25.55M 10-Q · filed 2016-11-14 | $54.57M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $19.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $33.57M 10-Q · filed 2017-08-10 | $43.14M derived: sum of 3 quarters · filed 2017-08-10 | $52.53M derived: sum of 4 quarters · filed 2017-08-10 | |
| 2016-03-31 | $13.80M 10-Q · filed 2017-05-12 | $23.37M derived: sum of 2 quarters · filed 2017-05-12 | $32.76M derived: sum of 3 quarters · filed 2017-05-12 | ||
| 2015-12-31 | $9.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $18.96M derived: sum of 2 quarters · filed 2017-03-31 | $52.22M 10-K · filed 2017-03-31 | ||
| 2015-09-30 | $9.39M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | $42.65M 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | $33.26M 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |